Literature DB >> 15148129

Botulinum toxin for masseter reduction in Asian patients.

Jeffrey Ahn1, Corinne Horn, Andrew Blitzer.   

Abstract

Asian patients frequently seek aesthetic alteration of hypertrophic masseter muscles to reduce a prominent mandibular angle. Surgical reduction is common in Asia, but botulinum toxin offers a less invasive approach. This pilot study evaluated results of aesthetic lower face narrowing in 20 Asian patients. Initially, 25 U of botulinum toxin (5 U/0.1 mL) was injected at each inferior masseter border; an additional 25 U was injected per side as needed at 1-week intervals. Seven patients (35%) required only 1 injection; 10 (50%) required 2; and 3 (15%) required 3 injections. Maximum reduction was seen at 1 to 2 months; more prominent hypertrophy yielded the most impressive results. Maintenance reinjection took place at 6 to 8 months. Up to 12 months of follow-up is reviewed herein. Two patients (10%) complained of mild fatigue after vigorous chewing and 1 developed mild transient buccal weakness. Nineteen of 20 patients were satisfied.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148129     DOI: 10.1001/archfaci.6.3.188

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  9 in total

1.  Botulinum Toxin A for Spastic Trismus Due to Brain Stem Encephalitis in a Pediatric Intensive Care Setting: A Unique Case Report.

Authors:  Fadi Kobal; Ayyoub Baqer; Jai Shanthini Singaram
Journal:  J Pediatr Intensive Care       Date:  2018-06-11

2.  Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism.

Authors:  Hatice Hosgor; Sezen Altindis
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-10-31

3.  Influence of injection of Chinese botulinum toxin type A on the histomorphology and myosin heavy chain composition of rat gastrocnemius muscles.

Authors:  Bin Hong; Min Chen; Xing-yue Hu
Journal:  J Zhejiang Univ Sci B       Date:  2013-11       Impact factor: 3.066

4.  Consensus on Current Injectable Treatment Strategies in the Asian Face.

Authors:  Woffles T L Wu; Steven Liew; Henry H Chan; Wilson W S Ho; Nantapat Supapannachart; Hong-Ki Lee; Adri Prasetyo; Jonathan Nevin Yu; John D Rogers
Journal:  Aesthetic Plast Surg       Date:  2016-02-18       Impact factor: 2.326

5.  The Anatomical Basis of Paradoxical Masseteric Bulging after Botulinum Neurotoxin Type A Injection.

Authors:  Hyung-Jin Lee; In-Won Kang; Kyle K Seo; You-Jin Choi; Seong-Taek Kim; Kyung-Seok Hu; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2016-12-30       Impact factor: 4.546

Review 6.  Botulinum neurotoxin formulations: overcoming the confusion.

Authors:  Souphiyeh Samizadeh; Koenraad De Boulle
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-30

7.  The Ideals of Facial Beauty Among Chinese Aesthetic Practitioners: Results from a Large National Survey.

Authors:  Souphiyeh Samizadeh
Journal:  Aesthetic Plast Surg       Date:  2018-10-04       Impact factor: 2.326

8.  The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.

Authors:  Mark S Nestor; David Arnold; Daniel Fischer
Journal:  J Cosmet Dermatol       Date:  2020-09-16       Impact factor: 2.696

9.  Comparison between Conventional Blind Injections and Ultrasound-Guided Injections of Botulinum Toxin Type A into the Masseter: A Clinical Trial.

Authors:  Hyungkyu Bae; Jisoo Kim; Kyle K Seo; Kyung-Seok Hu; Seong-Taek Kim; Hee-Jin Kim
Journal:  Toxins (Basel)       Date:  2020-09-11       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.